Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.

Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.

Choi HS, Yoo IeR, Park HL, Choi EK, Kim SH, Lee WH.

Clin Imaging. 2014 Mar-Apr;38(2):109-14. doi: 10.1016/j.clinimag.2013.11.011. Epub 2013 Nov 27.

PMID:
24361174
2.

Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.

Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH.

Skeletal Radiol. 2008 May;37(5):415-21. doi: 10.1007/s00256-008-0462-3. Epub 2008 Feb 29.

PMID:
18309481
3.

Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.

Choi JY, Lee KS, Kim HJ, Shim YM, Kwon OJ, Park K, Baek CH, Chung JH, Lee KH, Kim BT.

J Nucl Med. 2006 Apr;47(4):609-15.

4.

Improved detection of bone metastases from lung cancer in the thoracic cage using 5- and 1-mm axial images versus a new CT software generating rib unfolding images: comparison with standard ¹⁸F-FDG-PET/CT.

Homann G, Mustafa DF, Ditt H, Spengler W, Kopp HG, Nikolaou K, Horger M.

Acad Radiol. 2015 Apr;22(4):505-12. doi: 10.1016/j.acra.2014.12.005. Epub 2015 Jan 10.

PMID:
25586709
5.

The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.

Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH.

Ann Nucl Med. 2008 Aug;22(7):603-9. doi: 10.1007/s12149-008-0151-2. Epub 2008 Aug 29.

PMID:
18756363
6.

Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.

Okada M, Shimono T, Komeya Y, Ando R, Kagawa Y, Katsube T, Kuwabara M, Yagyu Y, Kumano S, Imaoka I, Tsuchiya N, Ashikaga R, Hosono M, Murakami T.

Ann Nucl Med. 2009 Jun;23(4):349-54. doi: 10.1007/s12149-009-0246-4. Epub 2009 Apr 2.

PMID:
19340526
7.

Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.

Seo YL, Yoon DY, Baek S, Lim KJ, Yun EJ, Cho YK, Bae WJ, Chung EJ, Kwon KH.

Eur Radiol. 2015 Jan;25(1):171-7. doi: 10.1007/s00330-014-3397-1. Epub 2014 Sep 3.

PMID:
25182627
8.

Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.

Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.

Ann Nucl Med. 2014 Nov;28(9):926-35. doi: 10.1007/s12149-014-0895-9. Epub 2014 Aug 9.

PMID:
25107363
9.

Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.

Chae EY, Cha JH, Kim HH, Shin HJ, Kim HJ, Oh HY, Koh YH, Moon DH.

Acta Radiol. 2012 Jun 1;53(5):530-5. doi: 10.1258/ar.2012.120015. Epub 2012 May 16.

PMID:
22593124
10.

The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.

Strobel K, Exner UE, Stumpe KD, Hany TF, Bode B, Mende K, Veit-Haibach P, von Schulthess GK, Hodler J.

Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2000-8. doi: 10.1007/s00259-008-0876-0. Epub 2008 Aug 20.

PMID:
18712385
11.

[Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].

Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.

Zhonghua Zhong Liu Za Zhi. 2012 May;34(5):364-8. doi: 10. 3760/cma.j.issn.0253-3766.2012.05.010. Chinese.

PMID:
22883458
12.

Significance of incidental focal uptake in prostate on 18-fluoro-2-deoxyglucose positron emission tomography CT images.

Han EJ, H O J, Choi WH, Yoo IR, Chung SK.

Br J Radiol. 2010 Nov;83(995):915-20. doi: 10.1259/bjr/19887771.

13.

The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.

Ozcan Kara P, Kara T, Kara Gedik G, Kara F, Sahin O, Ceylan Gunay E, Sari O.

Nucl Med Commun. 2011 Feb;32(2):106-12. doi: 10.1097/MNM.0b013e32834199e7.

PMID:
21085046
14.

Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.

Morita M, Higuchi T, Achmad A, Tokue A, Arisaka Y, Tsushima Y.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1672-81. doi: 10.1007/s00259-013-2487-7. Epub 2013 Sep 5.

PMID:
24006150
15.

Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.

Tian R, Su M, Tian Y, Li F, Li L, Kuang A, Zeng J.

Skeletal Radiol. 2009 May;38(5):451-8. doi: 10.1007/s00256-008-0643-0. Epub 2009 Feb 10.

PMID:
19205695
16.

Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?

van Hoeij FB, Keijsers RG, Loffeld BC, Dun G, Stadhouders PH, Weusten BL.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):66-71. doi: 10.1007/s00259-014-2887-3. Epub 2014 Aug 20.

PMID:
25139518
17.

Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.

Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.

J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068.

PMID:
23278193
18.

Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.

Cho WI, Chang UK.

J Neurosurg Spine. 2011 Feb;14(2):177-83. doi: 10.3171/2010.10.SPINE10175. Epub 2011 Jan 7.

PMID:
21214309
20.

Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.

Hur J, Yoon CS, Ryu YH, Yun MJ, Suh JS.

J Comput Assist Tomogr. 2007 Sep-Oct;31(5):812-9.

PMID:
17895798

Supplemental Content

Support Center